Summer Illnesses to Watch Out For

by pharmacy on September 6, 2017

Plenty of illnesses are associated with specific seasons. Although you can technically have the flu at any time of the year, winter is when it flourishes and is passed around heavily. Summer time may be associated with outdoor fun, beaches, swimming, and barbecues but it also hosts its own illnesses to keep an eye out for. Read on for a few things to watch out for this year! [click to continue…]


The Fight Against Heart Disease

by pharmacy on August 30, 2017

heart disease treatmentHeart disease is the number one killer of both men and women in the US, regardless of race. It has been the number one killer for the last 80 years. Despite the fact that it’s so deadly, we are finally seeing fewer people die each year from heart disease. What are we doing that is working? [click to continue…]


The 289 Billion Dollar Pharmaceutical Market

by pharmacy on August 23, 2017

pharmacy industryIn 2014, the pharmaceutical sector saw a big boom in business and they became the $289 billion market in drug and medical aid sales. How have we come so far that we are selling that much? Are we in for a market bust in the future? [click to continue…]


The Latest Trends in Pharma

by pharmacy on August 16, 2017

trends in pharmaThe pharmaceutical sector saw major growth in 2014; since then, it’s been a routine roller coaster ride with no clear indication of what will happen next. Part of what contributes to that is an election year, and 2016 was volatile in both the pharmaceutical and political arenas. However, 2017 is proving to be a year that will smooth out that ride and lead to incredible and fantastic growth in future years. [click to continue…]


Immune Cells and the Link to Immunotherapy

by pharmacy on August 9, 2017

immunotherapyImmunotherapy has been around for quite some time, and it’s one of the therapies in the fight against cancer that could change the way we look at cancer treatment. However, even the most successful treatments still face an uphill battle when it comes to the intricacies of cancer. Immunotherapy is successful in about 10-30% of cancer patients with specific types of tumors. Even some of the more aggressive cancers have been treated with immunotherapy simply based on the type of tumor that has been growing. For a long time now, no one has been able to answer why exactly the number has remained so low, but researchers at University of Pittsburgh School of Medicine and UPMC may have found a clue that could unlock the power of immunotherapy drugs and raise their success rates. [click to continue…]


lung cancerLung cancer is the second most common form of cancer in patients across the country. Unfortunately, it’s also the cause of the highest rates of suicide amongst cancer patients. It’s theorized the reason behind this is the low survival rate amongst lung cancer patients. This is often attributed to the fact that a large majority of the patients are diagnosed late in the game. Without any early warning signs, it’s very difficult to catch lung cancer early enough to make survival a likelihood. [click to continue…]


© RPh on the Go, All Rights Reserved.